Maelor

Maelor Pharmaceuticals is a specialist pharmaceutical company based in the United Kingdom, focusing on the development and supply of niche products for the healthcare market. The company's portfolio primarily serves therapeutic areas such as urology, critical care, and anesthesia, with a strong emphasis on catheter maintenance solutions and intravenous fluids. Maelor is well-known for its OptiFlo range, which is widely used within the National Health Service (NHS) for managing long-term urinary catheters. By targeting underserved clinical niches, the company provides essential medical products and devices that improve patient outcomes and healthcare efficiency. Headquartered in Wrexham, Wales, Maelor operates as an independent entity following its divestment from Dechra Pharmaceuticals in 2009.